APA

Spanggaard I., Snoj M., Cavalcanti A., Bouquet C., Sersa G., Robert C., Cemazar M., Dam E., Vasseur B., Attali P., Mir L. M. & Gehl J. (20140501). Gene electrotransfer of plasmid antiangiogenic metargidin peptide (AMEP) in disseminated melanoma: safety and efficacy results of a phase I first-in-man study. : Human gene therapy. Clinical development.

Chicago

Spanggaard Iben, Snoj Marko, Cavalcanti Andrea, Bouquet Céline, Sersa Gregor, Robert Caroline, Cemazar Maja, Dam Elisabeth, Vasseur Bérangère, Attali Pierre, Mir Lluis M and Gehl Julie. 20140501. Gene electrotransfer of plasmid antiangiogenic metargidin peptide (AMEP) in disseminated melanoma: safety and efficacy results of a phase I first-in-man study. : Human gene therapy. Clinical development.

Harvard

Spanggaard I., Snoj M., Cavalcanti A., Bouquet C., Sersa G., Robert C., Cemazar M., Dam E., Vasseur B., Attali P., Mir L. M. and Gehl J. (20140501). Gene electrotransfer of plasmid antiangiogenic metargidin peptide (AMEP) in disseminated melanoma: safety and efficacy results of a phase I first-in-man study. : Human gene therapy. Clinical development.

MLA

Spanggaard Iben, Snoj Marko, Cavalcanti Andrea, Bouquet Céline, Sersa Gregor, Robert Caroline, Cemazar Maja, Dam Elisabeth, Vasseur Bérangère, Attali Pierre, Mir Lluis M and Gehl Julie. Gene electrotransfer of plasmid antiangiogenic metargidin peptide (AMEP) in disseminated melanoma: safety and efficacy results of a phase I first-in-man study. : Human gene therapy. Clinical development. 20140501.